Postoperative Radiation With or Without Concurrent Chemotherapy for Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma With Multiple Intermediate Risks: A Propensity Score‐Matched Study

Ähnliche Einträge

• Early recurrence, time‐to‐recurrence, and recurrence patterns: Assessing their impact on survival outcomes in head and neck squamous cell carcinoma (R/M‐HNSCC) patients treated with first line platinum‐based chemotherapy
  von: Pasvich Pitakpaiboonkul, et al.
  Veröffentlicht: (2024)
• Immune reconstitution in children after haploidentical haematopoietic stem cell transplantation
  von: Saranthorn Apasuthirat, et al.
  Veröffentlicht: (2024)
• CAST: Time-Varying Treatment Effects with Application to Chemotherapy and Radiotherapy on Head and Neck Squamous Cell Carcinoma
  von: Yang, Everest, et al.
  Veröffentlicht: (2025)
• Postoperative Adjuvant Chemoradiotherapy ±  PD ‐1 Inhibitor for Locally Advanced Head and Neck Squamous Cell Carcinoma
  von: Zhiqiang Wang, et al.
  Veröffentlicht: (2026)
• Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
  von: Aarti Bhatia, et al.
  Veröffentlicht: (2025)